News

As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]

As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]

As part of the EHA conference, Prof Harry Iland launched the APML5 interim clinical trial results, a comparative bioavailability study of oral sodium hydrogen diarsenic tetroxide and intravenous [...]

The Australasian Leukaemia and Lymphoma Group (ALLG) held its May 2019 Scientific Meeting (SM) in Sydney with over 300 members, associate members, professional staff and affiliated guests in [...]

On 21 March 2019, the ALLG in conjunction with the VCCC hosted ‘AML in 2019 and Beyond’ at Walter and Eliza Hall Institute of Medical Research.

Last year, the Liberal National Government announced that they will provide $38.6 million to support 23 new clinical trials to improve treatments and discover cures for debilitating and deadly [...]

Late last year, the ALLG appointed Marina Mullins in the role of ALLG Operations Manager. She manages both the programme of ALLG clinical trials, and the staff of the ALLG Trial Centre.

We are all extremely saddened to announce that internationally renowned and respected Professor Bertrand Coiffier passed away on 2 January 2019 at the age of 71.

This year, ALLG achieved an increase in the number and participation of clinical trials, an increase in member engagement, and improved site commitment to the trial program. Thank you to all the [...]

The Australasian Leukaemia and Lymphoma Group (ALLG) held its November 2018 Scientific Meeting (SM) in Brisbane with 111 members in attendance.

The recent Blood 2018 meeting in Brisbane was definitely a highlight of this year. The ALLG had the opportunity to set up a display booth outlining our most recent clinical trials and to raise [...]

September is 'blood cancer awareness month', and we had the opportunity to take part in a number of conferences, workshops and summits to raise awareness of who we are and to promote our work in [...]